ARTICLE | Clinical News
Salmedix starts NHL Phase II
May 5, 2004 7:00 AM UTC
Salmedix (San Diego, Calif.) began a Phase II trial of its SDX-105 bendamustine in combination with Rituxan rituximab to treat patients with relapsed, indolent or slowly progressing non-Hodgkin's lymp...